Sarcopenia (loss of muscle) which affects up to 20 percent of European seniors, may increase 63 percent by 2045
Sarcopenia is a disease associated with the ageing process. Hallmark signs of the disorder are loss of muscle mass and strength, which in turn affects balance, gait and overall ability to perform tasks of daily living. This study assessed the prevalence of sarcopenia in Europe, finding that, when using the definition providing the highest prevalence estimates, the number of individuals with sarcopenia in Europe will rise by 63.8 percent in 2045.
Leave a Reply